IL49822A - Pharmaceutical compositions containing 9-(b-d-arabinofuranosyl)purine-5'-phosphates - Google Patents

Pharmaceutical compositions containing 9-(b-d-arabinofuranosyl)purine-5'-phosphates

Info

Publication number
IL49822A
IL49822A IL49822A IL4982276A IL49822A IL 49822 A IL49822 A IL 49822A IL 49822 A IL49822 A IL 49822A IL 4982276 A IL4982276 A IL 4982276A IL 49822 A IL49822 A IL 49822A
Authority
IL
Israel
Prior art keywords
arabinofuranosyl
purine
phosphates
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL49822A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL49822A publication Critical patent/IL49822A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Artificial Filaments (AREA)
IL49822A 1975-06-17 1976-06-17 Pharmaceutical compositions containing 9-(b-d-arabinofuranosyl)purine-5'-phosphates IL49822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25768/75A GB1562899A (en) 1975-06-17 1975-06-17 Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof

Publications (1)

Publication Number Publication Date
IL49822A true IL49822A (en) 1979-11-30

Family

ID=10232986

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49822A IL49822A (en) 1975-06-17 1976-06-17 Pharmaceutical compositions containing 9-(b-d-arabinofuranosyl)purine-5'-phosphates

Country Status (17)

Country Link
US (1) US4136175A (OSRAM)
JP (1) JPS52295A (OSRAM)
AU (1) AU507515B2 (OSRAM)
BE (1) BE843082A (OSRAM)
CA (1) CA1052309A (OSRAM)
CH (1) CH632771A5 (OSRAM)
CS (2) CS192000B2 (OSRAM)
DE (1) DE2627156A1 (OSRAM)
DK (1) DK139727B (OSRAM)
FI (1) FI61315C (OSRAM)
FR (1) FR2361901A1 (OSRAM)
GB (1) GB1562899A (OSRAM)
HU (1) HU176046B (OSRAM)
IL (1) IL49822A (OSRAM)
NL (1) NL7606576A (OSRAM)
SE (1) SE429656B (OSRAM)
ZA (1) ZA763611B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58763B2 (ja) * 1978-07-18 1983-01-07 三井造船株式会社 浮き防氷堤
EP0015584A3 (de) * 1979-03-12 1980-12-10 Kailash Kumar Dr. Prof. Gauri Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
US4315000A (en) 1980-07-07 1982-02-09 Warner-Lambert Company β-D-Arabinofuranosylimidazo(4,5-c)pyridine compounds and methods for their production
US4352795A (en) 1981-01-29 1982-10-05 Warner-Lambert Company 7-β-D-Arabinofuranosyl-7H-pyrrolo[2,3-d]pyrimidine compounds and methods for their production
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
US4594415A (en) * 1982-03-29 1986-06-10 Robins Roland K Azole dinucleotide compositions and methods of use
DE3784655T2 (de) * 1986-12-18 1993-07-15 Kyowa Hakko Kogyo Kk Verfahren zur herstellung von ascorbinsaeure-2-phosphat.
WO1992000312A1 (en) * 1990-06-27 1992-01-09 Ash Stevens, Inc. Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate
US5866429A (en) * 1991-04-03 1999-02-02 Bloch; Will Precision and accuracy of anion-exchange separation of nucleic acids
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
TW593331B (en) * 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
CN1245166C (zh) * 2000-11-08 2006-03-15 生物概念实验室 改进的含有单糖类作为防腐增强剂的眼科和隐形眼镜用溶液
CA2428994C (en) * 2000-11-08 2010-05-11 Bio-Concept Laboratories Improved ophthalmic and contact lens solutions containing forms of vitamin b
US6624203B1 (en) * 2001-11-08 2003-09-23 Francis X. Smith Nucleic acid bases used in ophthalmic solutions
US20040127435A1 (en) * 2002-08-02 2004-07-01 Regents Of The University Of California Uses for inhibitors of inosine monophosphate dehydrogenase
WO2004091438A2 (en) * 2003-04-15 2004-10-28 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing peptides as representative enhancers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328389A (en) * 1964-08-07 1967-06-27 Sankyo Co Process for preparing nucleotide derivatives
US3300478A (en) * 1965-06-01 1967-01-24 Upjohn Co Arabinofuranosyl 2', 5'-and 3'-5'-dinucleoside phosphates and process therefor
US3382232A (en) * 1965-08-26 1968-05-07 Takeda Chemical Industries Ltd Method for the production of 5'-ribonucleotide
US3337530A (en) * 1965-09-20 1967-08-22 Upjohn Co Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety
US3448098A (en) * 1966-09-27 1969-06-03 Merck & Co Inc Production of guanylic acid
BE756704A (fr) * 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
GB1386584A (en) * 1970-11-16 1975-03-12 Wellcome Found Method of preparation of purine sugar derivatives
GB1386585A (en) * 1970-11-16 1975-03-12 Wellcome Found Purine sugar derivatives
CA1023355A (en) * 1973-03-19 1977-12-27 Icn Pharmaceuticals 9-.beta.-D-ARABINOFURANOSYL PURINE NUCLEOTIDES

Also Published As

Publication number Publication date
CA1052309A (en) 1979-04-10
FR2361901B1 (OSRAM) 1978-12-15
CS192000B2 (en) 1979-07-31
HU176046B (en) 1980-11-28
GB1562899A (en) 1980-03-19
DK139727C (OSRAM) 1979-09-17
DE2627156A1 (de) 1977-01-13
AU1500476A (en) 1977-12-22
SE7606913L (sv) 1976-12-18
US4136175A (en) 1979-01-23
NL7606576A (nl) 1976-12-21
DK139727B (da) 1979-04-02
FR2361901A1 (fr) 1978-03-17
BE843082A (fr) 1976-12-17
ZA763611B (en) 1978-01-25
DK271876A (OSRAM) 1976-12-18
FI61315C (fi) 1982-07-12
CS191976B2 (en) 1979-07-31
FI761759A7 (OSRAM) 1976-12-18
AU507515B2 (en) 1980-02-21
CH632771A5 (de) 1982-10-29
SE429656B (sv) 1983-09-19
JPS52295A (en) 1977-01-05
FI61315B (fi) 1982-03-31

Similar Documents

Publication Publication Date Title
IL49822A (en) Pharmaceutical compositions containing 9-(b-d-arabinofuranosyl)purine-5'-phosphates
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
IL50047A (en) Somatostatin analogs,their preparation and pharmaceutical compositions containing them
ZA763917B (en) Pharmaceutical compositions and compounds
IL50631A (en) 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
KE3219A (en) Pharmaceutical compositions
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
NZ180193A (en) Antiviral compositions pharmaceutical or disinfectant
IL48997A0 (en) Therapeutic compositions containing xylitol
AU1306576A (en) Pharmaceutical formulation
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
GB1555991A (en) Pharmaceutical compositions containing adenosine derivatives
ZA767215B (en) Pharmaceutical compositions
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
ZA761880B (en) New pharmaceutical compositions
ZA761012B (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
IL61826A0 (en) Pharmaceutical compositions containing pyranoquinolinone derivatives
ZA763806B (en) Pharmaceutical compositions
JPS51148027A (en) Medicine containing 11*2*66dimethylphenoxy**22 methylaminopropane